immunosuppressant

CellCept 500 mg (mycophenolate mofetil) is a prescription immunosuppressant medication. Its primary use is to prevent the body from rejecting transplanted organs—specifically kidney, liver, and heart transplants. It weakens the immune system so it does not attack the new organ.Primary UsesOrgan Transplant Rejection Prevention: Used in adults and children over 3 months of age, typically alongside other immunosuppressants (like corticosteroids or cyclosporine).Off-Label Autoimmune Treatments: Dermatologists and rheumatologists may prescribe it off-label to treat severe autoimmune conditions, such as lupus, systemic sclerosis, or vasculitis.Important Safety InformationPregnancy Warning: CellCept can cause miscarriages and severe birth defects. Effective birth control is required for both men and women during and shortly after treatment.Infection Risk: Because it suppresses the immune system, it increases your risk of serious infections and certain cancers.For official prescribing guidelines or to check approved indications in your specific region, refer to the detailed Drugs.com CellCept Profile or consult your transplant specialist.

Tofacitinib 11 mg tablets are used to treat chronic inflammatory conditions by suppressing the immune system, specifically for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, and juvenile idiopathic arthritis. It works as a Janus kinase (JAK) inhibitor to reduce joint pain, stiffness, and inflammation.

Tofacitinib 5 mg tablets are used to treat chronic inflammatory conditions by suppressing the immune system, specifically for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, and juvenile idiopathic arthritis. It works as a Janus kinase (JAK) inhibitor to reduce joint pain, stiffness, and inflammation.

Sirolimus 5 mg tablets (e.g., Siromus, Rapamune) are immunosuppressant medications primarily used to prevent organ rejection in adult kidney transplant patients. By suppressing the immune system, it helps the body accept the new organ. It is also used to treat sporadic lymphangioleiomyomatosis (S-LAM), a rare lung disease.

Sirolimus 3 mg tablets (e.g., Siromus, Rapamune) are immunosuppressant medications primarily used to prevent organ rejection in adult kidney transplant patients. By suppressing the immune system, it helps the body accept the new organ. It is also used to treat sporadic lymphangioleiomyomatosis (S-LAM), a rare lung disease.

Sirolimus 2 mg tablets (e.g., Siromus, Rapamune) are immunosuppressant medications primarily used to prevent organ rejection in adult kidney transplant patients. By suppressing the immune system, it helps the body accept the new organ. It is also used to treat sporadic lymphangioleiomyomatosis (S-LAM), a rare lung disease.

Sirolimus 1 mg tablets (e.g., Siromus, Rapamune) are immunosuppressant medications primarily used to prevent organ rejection in adult kidney transplant patients. By suppressing the immune system, it helps the body accept the new organ. It is also used to treat sporadic lymphangioleiomyomatosis (S-LAM), a rare lung disease.